Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6809021 | 0.99 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL6808872 | 0.85 | TSHR (0.52) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL6809092 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TSHRHTTL3MBTL1TP53 | |
| Hydrochloric Acid SCHEMBL6809032 | 0.84 | TSHR (0.51) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL6807966 | 0.84 | TSHR (0.36) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| Hydrochloric Acid SCHEMBL6808628 | 0.84 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| Hydrochloric Acid SCHEMBL6812948 | 0.84 | SMN1; SMN2 (0.36) | SMN1; SMN2ALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL14597832 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL6808023 | 0.81 | CTSL (0.49) | CTSK | |
| Hydrochloric Acid SCHEMBL6809074 | 0.80 | CTSL (0.49) | SMN1; SMN2CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040204368-A1 | Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204368-A1 | Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient | ACIN1, CASP3, CASP7 | SMN1; SMN2 1536/4885ALDH1A1 1531/4885TSHR 1975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.